As Deadline For CFC Inhalers Looms, Firms Offer Incentives For HFA Switch

By the end of the year, metered dose inhalers containing chlorofluorocarbon (CFC) propellants will no longer be on the market. While consumers with asthma or chronic bronchitis will have no choice but to switch to alternative hydrofluoroalkane (HFA)-propelled products, many have been reluctant to do so

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet